Total Aβ was similar among the different cell treatments, although we noted a slight trend for a reduction in total Aβ in N2a-APPswe-PrP − cells and an increase in N2a-APPswe-PrP A116V cells, compared with N2a-APPswe-CTL cells (Fig. 6C ).
← all excerpts
"Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrP<sup>C</sup>-dependent secretion of Aβ.
1
—
—